CCH registration is OPEN!

Demonstrate your commitment to your patients and practice at APC’s annual DC fly-in for pharmacy compounders, September 17-18 at Hilton National Mall.

Demonstrably difficult list, demonstrably problematic

The FDA is proposing a rule that would add categories to both the 503A and 503B demonstrably difficult to compound (DDC) lists — a plan that has a host of issues.

APC to CA BOP: How does this make patients safer?

The California Board of Pharmacy has proposed several new regulations for pharmacy compounding, some of which, to put it bluntly (and we did put it bluntly), are not rooted in science or evidence.

Truth and GLP-1s

Compounded GLP-1 drugs. Perhaps you’ve heard about them?

PCF names new directors

The Pharmacy Compounding Foundation has elected five board members

Our state-by-state 795-797-800 chart has been updated

APC has posted an updated version of our compilation of state by state adoption of USP <795>, <797>, and <800>.

Novo alleges potency discrepancy, impurities in compounded semaglutide

We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no? 

APC files amicus in Novo case against Tennessee compounder

A U.S. District Court judge approved APC filing an amicus brief this week in Novo Nordisk’s lawsuit against Tennessee compounder (and APC PFM) DCA Pharmacy.

A $100,000 deficit

One of the challenges of being an ambitious but resource-poor association is that we have to spend a lot of time asking members like you for money.

Telling your story, one reporter at a time

The photo inset below on the left was taken last Friday morning at Preston’s Pharmacy (a PFM, I might add) in Arlington, Virginia. It’s not a pharmacist or technician in the photo. It’s a healthcare reporter.

There’s a lot you can learn from errors

Patient safety is job one in any pharmacy, but especially in compounding pharmacies. So on those rare occasions when errors occur — in your pharmacy or someone else’s — you want to be able to learn from them.

What does FD&C Act really say about USP compliance?

In response to inquiries from state boards of pharmacy regarding the enforceability of revised USP Chapters <795>, <797>, and <800>, a recent memo aims to clarify references in the Food, Drug & Cosmetic Act.

Letter seeks clarity on semaglutide compounding in California

Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide.

There’s a committee for that

APC is recruiting committee members for 2024.

Welcome to our new PFMs!

The number of APC Pharmacy-Facility Members continues to grow.

FAQs and other new-chapter resources from USP

APC leaders met this week with USP staff for a touch-base. One outcome of that meeting is the need to spread the word about several USP compounding resources.

Court publishes dismissal in Novo case against Brooksville

In a ruling published this week, the U.S. District Court for the Middle District of Florida, Tampa Division, granted a motion to dismiss in the case of Novo Nordisk, Inc. v. Brooksville Pharmaceuticals.

Bad journalism, ketamine studies, and scammers

I don’t have a clever theme to unite the three things I want to share this week, so I’ll just dive in...

APC members honored by PCCA

Updated PCAB standards available

PCAB announced this week that updated PCAB Accreditation Standards are now available to download.

Meet your 2024 Board of Directors

In elections that closed last week, the APC membership elected (or re-elected) five board members.

Perplexed by new USP standards?

We’ve got resources for you!

What do BOPs think about compounding?

This week APC sent a 15-question survey to members and directors of state boards of pharmacy to gauge their views on the regulation of pharmacy compounding in their state.

A procedural pathway to Category 1

The addition by FDA of several peptides to Category 2 on September 29 officially placed them out of reach for compounding, at least for the time being.

Medisca is APC’s first $100k Patron

Pharma Source Direct bumps up its support for 2024, too.

Mark your calendar (doggone it!)

2024 is coming fast, and before you know, your calendar will fill up.

APC requests transparency on new Cat 2 substances

In a letter this week to Gail Bormel, director of FDA’s Office of Compounding Quality and Compliance, APC called for transparency regarding the recent addition of substances to Category 2.

A righteous rant

When it comes to tutoring reporters about pharmacy compounding in the media, I feel sometimes like I’m in one of those old Tom & Jerry cartoons.

Pharmacy Compounding Foundation offers technician grants

The Pharmacy Compounding Foundation will be offering up to ten (10) pharmacy technicians a grant valued at up to $495 to attend the APC, PCF, VCU online 15-hour curriculum.

Draft GFI on ophthalmics, final GFI on alcohol testing issued

FDA has released two new guidance documents this month that APC members will want to familiarize themselves with.